{"title":"Selective inhibition of cathepsin S elastolytic activity by exopolysaccharides from deep-sea hydrothermal bacteria","authors":"Alexis David , Baptiste Rigoux , Martyna Maszota-Zieleniak , Corinne Sinquin , Catherine Neau , Agata Zykwinska , Ahlame Saidi , Gilles Lalmanach , Sergey A. Samsonov , Sylvia Colliec-Jouault , Fabien Lecaille","doi":"10.1016/j.carbpol.2025.123968","DOIUrl":null,"url":null,"abstract":"<div><div>Human cathepsin S (CatS) constitutes a key orchestrator of extracellular matrix (ECM) remodeling. Recent evidence suggest that CatS inhibition is a valuable therapeutic option for inflammatory diseases that are characterized by an excessive degradation of insoluble elastin, a process in which CatS contributes significantly when it is overexpressed. Here, we report novel findings that highlight the inhibition of CatS by two low-molecular weight highly sulphated exopolysaccharides (EPS), named diabolican (Dia<sub>9-Hsulf</sub>) and infernan (Inf<sub>19-Hsulf</sub>), derived from two marine bacterial strains <em>Vibrio diabolicus and Alteromonas infernus</em>, respectively. Dia<sub>9-Hsulf</sub> and to a lesser extent Inf<sub>19-Hsulf</sub> were selective and potent uncompetitive inhibitors of CatS (nanomolar range), which represents an unprecedented mechanism of CatS inhibition. In addition, both EPS selectively inhibited the elastolytic activity of CatS, without affecting the degradation of its other biological substrates (e.g. collagen, thyroglobulin). Combined experimental and in silico approaches provided new insights on how highly sulfated diabolican prevented the CatS elastolytic activity by hindering its elastin-binding exosite. These results evidenced EPS as promising molecules to preserve the elastin integrity during inflammatory events implying CatS.</div></div>","PeriodicalId":261,"journal":{"name":"Carbohydrate Polymers","volume":"367 ","pages":"Article 123968"},"PeriodicalIF":10.7000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Carbohydrate Polymers","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0144861725007519","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
Human cathepsin S (CatS) constitutes a key orchestrator of extracellular matrix (ECM) remodeling. Recent evidence suggest that CatS inhibition is a valuable therapeutic option for inflammatory diseases that are characterized by an excessive degradation of insoluble elastin, a process in which CatS contributes significantly when it is overexpressed. Here, we report novel findings that highlight the inhibition of CatS by two low-molecular weight highly sulphated exopolysaccharides (EPS), named diabolican (Dia9-Hsulf) and infernan (Inf19-Hsulf), derived from two marine bacterial strains Vibrio diabolicus and Alteromonas infernus, respectively. Dia9-Hsulf and to a lesser extent Inf19-Hsulf were selective and potent uncompetitive inhibitors of CatS (nanomolar range), which represents an unprecedented mechanism of CatS inhibition. In addition, both EPS selectively inhibited the elastolytic activity of CatS, without affecting the degradation of its other biological substrates (e.g. collagen, thyroglobulin). Combined experimental and in silico approaches provided new insights on how highly sulfated diabolican prevented the CatS elastolytic activity by hindering its elastin-binding exosite. These results evidenced EPS as promising molecules to preserve the elastin integrity during inflammatory events implying CatS.
期刊介绍:
Carbohydrate Polymers stands as a prominent journal in the glycoscience field, dedicated to exploring and harnessing the potential of polysaccharides with applications spanning bioenergy, bioplastics, biomaterials, biorefining, chemistry, drug delivery, food, health, nanotechnology, packaging, paper, pharmaceuticals, medicine, oil recovery, textiles, tissue engineering, wood, and various aspects of glycoscience.
The journal emphasizes the central role of well-characterized carbohydrate polymers, highlighting their significance as the primary focus rather than a peripheral topic. Each paper must prominently feature at least one named carbohydrate polymer, evident in both citation and title, with a commitment to innovative research that advances scientific knowledge.